معرفی
John Y. Rhee, MD, MPH is an Instructor of Neurology at Harvard Medical School and a dual-appointed Physician at the Dana-Farber Cancer Institute, serving in the Division of Adult Palliative Care and the Center for Neuro-Oncology. He specializes in the comprehensive care of patients with central nervous system cancers, integrating neuro-oncology treatment with palliative care services to address complex symptom burden and enhance quality of life.
Dr. Rhee's educational background includes:
- Medical Degree and Master of Public Health (MD/MPH) from the Icahn School of Medicine at Mount Sinai
- Neurology Residency at Mass General Brigham, where he served as Chief Resident
- Fellowship in Hospice and Palliative Medicine at Mass General Brigham / Dana Farber Cancer Institute
- Fellowship in Neuro-Oncology at Massachusetts General Hospital/Brigham and Women’s Hospital/Dana-Farber Cancer Institute
His research program focuses on advancing supportive care interventions for neuro-oncology patients, with particular emphasis on symptom management for conditions including glioblastoma, brain metastases, and primary CNS lymphoma. He directs a dedicated supportive care clinic and research initiative at Dana-Farber aimed at improving daily functioning and lived experience for patients with CNS tumors through innovative clinical approaches.
Dr. Rhee has received significant recognition as a Young Member of the Pontifical Academy of Life, reflecting his contributions to bioethics and medical ethics at the Vatican advisory level. This honor complements his clinical and research work in neuro-oncology palliative care.
Information regarding formal student advising and specific research grants was not available in the source materials. However, his leadership in establishing the CNS tumor supportive care program demonstrates active engagement in clinical innovation and research mentorship within multidisciplinary settings.
At Dana-Farber, Dr. Rhee collaborates extensively within Neuro-Oncology and Adult Palliative Care teams, working alongside oncologists, neurologists, nurses, social workers, and other specialists to deliver holistic care for patients with complex neurological malignancies while addressing language needs through fluency in Korean and Spanish.
